Hi Bearman.i hear what you are saying. That would mean 2.5 years...

Hi Bearman.

i hear what you are saying. That would mean 2.5 years ( coming on 3 years in jan2021) of constant 'impatience' and selling down mdc to -90% of value despite strong efforts of company growth and announcements. I feel this was by design as prior to the 20mill raised at 90c for phase2 nanabis there was very little shares for sale and at most 80000 shares considered a large sell order. Very iliquid stock. Knowing many years away from nanabis drug approval i believe a technique has been employed to create impatience and shorting by design. Tables will turn at some point and those selling down at these mc levels may regret it. And those in the know buying at the lows will be the made millionaires.
i understand plethora of pot stocks and hype died down is why i think those shorting sp used it as an excuse (follow suit) to execute this selldown the way it has been done.

usually biotech stocks with billions shares sky rocket on positive trial results especially phase2. Look what happened to BOT on super average phase1 results catepulted to 300mill mc (4c-30c)... with 1 bill shares on offer, no income, 1 prototype of a cream. Mdc went the other way on meeting their phase2 goal success.. down 50%.. is why its suspicious in my eyes. Usually stocks that go down significantly on positive results are the ones that will have big gains. Whereas usually stocks that are awaiting trial results go up 300% always have poor results. Is why the sp movement in mdc over last 3 years makes no sense. Insiders never want to buy at retail price they want 90% discount.
there are 3 billion dollar pharmaceutical companies with interest in Nanabis now and im sure they want a piece of the pie.. hense the sp over last 3 years.

or you are correct it is just a result of impatient retail investors.